I tumori della parete toracica. Nostra esperienza.

Translated title of the contribution: Tumors of the thoracic wall. Our experience

P. Carbognani, L. Spaggiari, M. Rusca, L. Cattelani, M. Valente, P. Bobbio

Research output: Contribution to journalArticle


Chest wall tumors are rare being less than 1% of all the neoplasms. While the treatment of benign tumor and of solitary metastatic is standardized, the therapy of the primary malignant is not the same for all the authors. From January 1980 to December 1993 46 patients affected by chest wall neoplasms, 29 men (63%) and 17 women (37%), mean age of 51 yrs. (range 31-77 yrs.), were treated surgically. For benign tumors only resection was performed while for malignant and metastatic tumors after the resection the reconstruction was performed respectively: in 11 cases with Marlex mesh, in 1 case with the omentum, in 2 cases with Marlex and Methyl Methacrylate. Muscle transposition was performed in 1 case with pectoralis major covering a Dura Mater prosthesis. We have no peroperative death and no complications in 37 (80%) patients. Minor complications in 9 cases; in 1 case the sternal prosthesis was removed for infection. The median follow up was of 40.50 months. Actually the 48% of patients with primary and metastatic tumor are alive. From our results we conclude that the wide radical resection with reconstruction when necessary is the treatment of choice for the tumors of the chest wall.

Translated title of the contributionTumors of the thoracic wall. Our experience
Original languageItalian
Pages (from-to)29-34
Number of pages6
JournalActa Biomedica
Issue number1-2
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Tumors of the thoracic wall. Our experience'. Together they form a unique fingerprint.

  • Cite this

    Carbognani, P., Spaggiari, L., Rusca, M., Cattelani, L., Valente, M., & Bobbio, P. (1994). I tumori della parete toracica. Nostra esperienza. Acta Biomedica, 65(1-2), 29-34.